Effect of bone marrow mesenchymal stem cells transfected with rAAV2-bFGF on early angiogenesis of calvarial defects in rats

被引:0
作者
Meiling Chen
Ke Song
Nianjing Rao
Mengqi Huang
Zhengjiang Huang
Yingguang Cao
机构
[1] Huazhong University of Science and Technology,Center of Stomatological Medicine, Tongji Hospital, Tongji Medical College
来源
Journal of Huazhong University of Science and Technology [Medical Sciences] | 2010年 / 30卷
关键词
basic fibroblast growth factor; gene therapy; angiogenesis; bone regeneration;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to evaluate the effect of bone marrow mesenchymal stem cells (MSCs) transfected with the basic fibroblast growth factor (bFGF)-expressing recombinant adeno-associated virus vector (rAAV2-bFGF), on early angiogenesis of calvarial defects in rats. The MSCs were cultured and transfected with rAAV2-bFGF after differential adherence isolation. The transfection efficiency was detected by RT-PCR and Western blotting. The transfected MSCs were compounded with poly-DL-lactide/hydroxyapatite (PDLLA/HA) in vitro. The cranial defect models in 36 male SD rats were created. Nothing (group A), PDLLA/HA alone (group B), PDLLA/HA combined with MSCs (group C), and PDLLA/HA combined with rAAV2-bFGF transfected MSCs (group D) were implanted in rat calvarial defects. The specimens were harvested for hematoxylin-eosin staining on the day 1, 3 and 7 after implantation. Factor VIII immunohistochemical staining and histomorphometric analysis were carried out to evaluate neovascularization around the implantation. The results indicated that MSCs could indeed be successfully transfected with the rAAV2-bFGF vector. Histological and histomorphometric analysis revealed that the angiogenesis in group D was significantly enhanced as compared with the rest groups (P<0.05). These results strongly suggest that MSCs transfected with rAAV2-bFGF in combination with PDLLA/HA can effectively promote the early angiogenesis of calvarial defects in rats, which played an important role in creating an environment suitable for the survival and activity of transplanted cells for further applications in cranio-maxillofacial bone regeneration.
引用
收藏
页码:519 / 524
页数:5
相关论文
共 40 条
[1]  
Sakakibara Y.(2003)Toward surgical angiogenesis using slow-released basic fibroblast growth factor Cardiothorac Surg 24 105-111
[2]  
Tambara K.(1994)Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels J Control Release 31 189-199
[3]  
Sakaguchi G.(2001)Adenovirus-mediated Gene Ther 8 837-845
[4]  
Tabata Y.(1995) gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia Cell Transplant 4 415-436
[5]  
Hijikata S.(1995)Implantable biohybrid artificial organs Crit Rev Oral Biol Med 6 230-247
[6]  
Ikada Y.(2006)The pathophysiology of angiogenesis Adv Drug Deliv Rev 58 577-591
[7]  
Ohara N.(2007)The role of gene therapy for craniofacial and dental tissue engineering Eur Cell Mater 13 93-99
[8]  
Koyama H.(2006)Adeno-associated viral vector transduction of human mesenchymal stem cells Biomed Mater 1 93-99
[9]  
Miyata T.(2005)Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds Hum Gene Ther 16 1413-1421
[10]  
Colton C.K.(1987)Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector Endocr Rev 8 95-114